Symbol="RSLS"
AssetType="Common Stock"
Name="ReShape Lifesciences Inc"
Description="ReShape Lifesciences Inc., a medical device company, provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company is headquartered in San Clemente, California."
CIK="1427570"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="5421 AVENIDA ENCINAS, SUITE F, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4178100"
EBITDA="-22945000"
PERatio="None"
PEGRatio="None"
BookValue="2.929"
DividendPerShare="0"
DividendYield="0"
EPS="-85.47"
RevenuePerShareTTM="14.61"
ProfitMargin="0"
OperatingMarginTTM="-2.219"
ReturnOnAssetsTTM="-0.483"
ReturnOnEquityTTM="-1.758"
RevenueTTM="11087000"
GrossProfitTTM="6802000"
DilutedEPSTTM="-85.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.063"
AnalystTargetPrice="8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.322"
PriceToBookRatio="0.162"
EVToRevenue="0.138"
EVToEBITDA="0.0414"
Beta="1.405"
num_52WeekHigh="26.5"
num_52WeekLow="1.31"
num_50DayMovingAverage="1.919"
num_200DayMovingAverage="5.57"
SharesOutstanding="2942300"
DividendDate="2019-07-25"
ExDividendDate="None"
symbol="RSLS"
open="1.42"
high="1.45"
low="1.40"
price="1.42"
volume="43057.00"
latest_trading_day="2023-08-01"
previous_close="1.42"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="254701"
Change_recent_avg="-0.02"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.77"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="632"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_positive_thumbnail_id_2="652"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
